Slingshot members are tracking this event:

Bayer (BAYRY) Releases Phase 3b PIONEER AF-PCI Results Evaluating Xarelto in Patients with Irregular Heartbeat After Percutaneous Coronary Intervention at the American Heart Association Scientific Sessions 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 14, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3b, Pioneer Af-pci, Xarelto, Irregular Heartbeat, Percutaneous Coronary Intervention, American Heart Association, Scientific Sessions 2016